Mental Health & Behavioral Research
Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.
Volunteers
Health Professionals
What is the purpose of this trial?
This study aims to investigate the effects of oral psilocybin on OCD symptomatology and provide the first evidence of the neural mechanism that may mediate psilocybin's purported therapeutic effects on OCD.
- Ages21 years - 55 years
- GenderBoth
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.
Principal Investigator
Sub-Investigators
- Last Updated02/22/2024
- Study HIC#2000020355